β-THALASSEMIA DISTRIBUTION IN THE OLD WORLD: A HISTORICAL STANDPOINT OF AN ANCIENT DISEASE  Vincenzo De Sanctis  DOI https://doi.org/10.4084/mjhid.2017.018

Pages e2017018   PDF     HTML

  PREGNANCY IN THALASSEMIA  Raffaella Origa, Federica Comitini  DOI https://doi.org/10.4084/mjhid.2019.019

Pages e2019019         PDF  HTML

 

DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA

 Ali Taher

 DOI https://doi.org/10.4084/mjhid.2018.066     Pages e2018066   PDF HTML

REVIEW AND RECOMMENDATIONS ON MANAGEMENT OF ADULT FEMALE THALASSEMIA PATIEΝTS WITH HYPOGONADISM BASED ON LITERATURE REVIEW AND EXPERIENCE OF ICET-A NETWORK SPECIALISTS  Vincenzo De Sanctis  DOI https://doi.org/10.4084/mjhid.2017.001

Pages e2017001  PDFHTML

   THYROID DISORDERS IN HOMOZYGOUS β-THALASSEMIA: CURRENT KNOWLEDGE, EMERGING ISSUES AND OPEN PROBLEMS  Vincenzo De Sanctis  DOI https://doi.org/10.4084/mjhid.2019.029

Pages e2019029        PDFHTML

  IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM.  Federica Pilo  DOI https://doi.org/10.4084/mjhid.2019.030

Pages e2019030        PDF     HTML 

  HYDROXYCARBAMINE: FROM AN OLD DRUG USED IN MALIGNANT HEMOPATHIES TO A CURRENT STANDARD IN SICKLE CELL DISEASE  Giovanna Cannas, Solene Poutrel, Xavier Thomas  DOI https://doi.org/10.4084/mjhid.2017.015

Pages e2017015   PDF  HTML

 

NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE

 Alessandro Matte, Filippo Mazzi, Enrica Federti, Oliviero Olivieri, Lucia De Franceschi

 DOI https://doi.org/10.4084/mjhid.2019.002     PDF HTML